License Agreement [Amendment No. 3] - Celsion Corp. and MMTC Inc.
THIRD AMENDMENT TO THE LICENSE AGREEMENT
This Third Amendment to the License Agreement (The "Third Amendment")
is made and entered into as of September 17, 2002 (the "Third Amendment
Effective Date"), by and between Celsion Corporation (formerly known as Cheung
Laboratories, Inc.), a Maryland corporation, having a principal place of
business at 10220-I Old Columbia Road, Columbia, MD 21046 ("Celsion") and MMTC,
Inc. a Delaware corporation, having a principal place of business at 12 Roszel
Road, Suite A-203, Princeton, New Jersey 08450 ("MMTC").
WHEREAS, Celsion and MMTC have previously entered into that certain
License Agreement dated August 23, 1996 as extended on April 11, 1997 (the
"Original Agreement") pursuant to which Celsion licenses contain intellectual
property from MMTC.
WHEREAS, the parties amended the Original Agreement by amendment dated
November 25, 1997 ("First Amendment") and dated March 13, 1999 ("Second
Amendment," the First Amendment, Second Amendment, Third Amendment and Original
Agreement, collectively, the "Agreement") and
WHEREAS, the parties desire to amend the provisions of the Agreement
upon the terms and conditions set forth herein.
NOW, THEREFORE, in consideration of foregoing and for other good and
valuable consideration, the receipt and adequacy of which are hereby
acknowledged, the parties hereby agree as follows:
1. Definitions. All capitalized terms used herein shall have the meanings as
assigned to such terms in the Agreement unless otherwise defined herein.
2. Additional Patent. The "Licensed Patents" listed on Appendix 1 shall include
U.S. Patent No. 5,99219 dated November 30, 1999 and filed on August 20, 1998
(Fred Sterzer and Daniel Mawhinney - Method Employing a Tissue-Heating Balloon
Catheter to Produce a "Biological Stent" in an Orifice or Vessel of a Patient's
Body) and any patents issuing in any and all countries of the world
corresponding to U.s. Patent No. 5,992,419, as well as any continuations,
divisions, re-examinations and reissues thereof. Disclosed in U.s. Patent No.
5,992,419 are three embodiments of a method for determining the formation of a
"Biological Stent" for permanently maintaining the widened bore portions of the
urethra of a male patient undergoing treatment for a disease of the prostate.
<PAGE>
3. Entire Agreement. This Third Agreement, together with the Original Agreement,
First Amendment and Second Amendment, constitute the entire understanding and
agreement of the parties with respect to the transactions contemplated herein
and supersedes all prior and contemporaneous understandings and agreements,
whether written or oral, with respect to such transactions.
4. Governing Law. This Agreement is made in accordance with and shall be
governed and construed under the laws of the State of New York, without regard
to its conflict of laws provisions.
IN WITNESS WHEREOF, the parties have executed this Third Amendment as
of the Third Amendment Effective Date.
CELSION CORPORATION MMTC, INC.
By: /s/ Daniel Reale By: /s/ Fred Sterzer
---------------------------- --------------------
Name: Daniel Reale Name: Fred Sterzer
Its: Executive Vice President Its: President
2